Skip to main content
SpringerLink
Log in

Consensus Guidelines for Evaluating and Treating Patients with Upper Gastrointestinal Symptoms in the Primary Care Setting

  • Original Research Article
  • Consensus Guidelines for UGI Symptoms
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Upper gastrointestinal (UGI) disease represents a significant part of the primary care physician’s workload and is ultimately responsible for a major portion of the costs relating to his or her drug prescribing. This paper outlines the scale of the problem and the possibility of a structured management plan for UGI disease. Although this type of strategy is not new, the International Gastro Primary Care Group (IGPCG) has approached it from a practical standpoint that addresses the concerns of general practitioners and the fears and anxieties of patients.

In addition, the direct representation of this model with a cost-effective programme is the first opportunity to develop strategies, in primary care, for testing a protocol for the management of UGI disease. The approach is aimed at the primary care setting and is adaptable for use in different cultural groups and healthcare systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jones R, Murfin D. Gastrointestinal problems in the community and in general practice. In: Jones R, editor. Gastrointestinal problems in general practice. Oxford: Oxford University Press, 1993

    Google Scholar 

  2. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259–68

    PubMed  CAS  Google Scholar 

  3. Knill-Jones RP. Diagnostic systems as an aid to clinical decision-making. BMJ 1987; 295: 1392–6

    Article  PubMed  CAS  Google Scholar 

  4. Oddsson E, Binder V, Thorgeirsson T, et al. A prospective comparative study of clinical and histological charactistics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer and x-ray negative dyspepsia. I. Design and clinical features. Scand J Gastroenterol 1977; 12: 689–94

    Article  PubMed  CAS  Google Scholar 

  5. Jones RH, Lydeard SE, Hobbs FD, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401–5

    Article  PubMed  CAS  Google Scholar 

  6. Agreus L, Svardsudd K, Nyren O, et al. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gasterenterol 1994; 29: 102–9

    Article  CAS  Google Scholar 

  7. Kang JY, Guan R, LaBrooy SJ, et al. The influence of sex, race and dialect on peptic ulcer and non-ulcer dyspepsia in Singapore. Ann Acad Med 1983; 12: 527–31

    CAS  Google Scholar 

  8. Gatumbi I, Roy AD. The prevalence of peptic ulcer dyspepsia in a rural community in Kenya. East Afr Med J 1970; 47: 627–33

    PubMed  CAS  Google Scholar 

  9. Milne R, Logan RP, Harwood D, et L. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. Gut 1995; 37 (3): 314–8

    Article  PubMed  CAS  Google Scholar 

  10. Breuer T, Sudhop T, Hoch J, et al. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol 1996; 8 (1): 47–52

    Article  PubMed  CAS  Google Scholar 

  11. McIntyre A-M, MacGregor S, Malek M, et al. New patients presenting to their GPs with dyspepsia: does Helicobacter pylori minimise the cost of managing these patients? Int J Clin Prac 1997; 51: 276–81

    CAS  Google Scholar 

  12. Bodger K, Daly MJ, Heatley RV, et al. Clinical economics review: gastroenterology. Aliment Pharmacol Ther 1996; 10 (1): 55–60

    Article  PubMed  CAS  Google Scholar 

  13. Whitaker MJ, Brun J, Carelli F, et al. Controversy and consensus in the management of upper gastrointestinal disease in primary care. Int J Clin Pract 1997; 51 (4): 239–43

    PubMed  CAS  Google Scholar 

  14. Valori RM, Brown CM, Strangeways P. Dyspepsia workshop for family doctors reduce dyspepsia drug costs: a controlled trial [abstract]. Gastroenterology 1996 Apr; 110 (4): A45

    Google Scholar 

  15. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia: report of a working party. Lancet 1998; I: 567–79

    Google Scholar 

  16. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study. Scand J Gastroenterol 1994; 29: 618–23

    Article  PubMed  CAS  Google Scholar 

  17. Heading RC. Definitions of dyspepsia. Scand J Gastroenterol 1991; 26 Suppl. 182: 1–6

    Article  Google Scholar 

  18. Inoue M, Sekiguchi T, Harasawa S, et al. Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride. Scand J Gastroenterol 1994; 29: 36–9

    Google Scholar 

  19. Haugstvedt TK, Viste A, Eide GE, et al. Factors related to and consequences of weight loss in patients with stomach cancer. The Norwegian Multicenter experience. The Norwegian Stomach Cancer Trial. Cancer 1991 Feb; 67 (3): 722–9

    Google Scholar 

  20. Heatley RV, Rathbone BJ. Dyspepsia: a dilemma for doctors? Lancet 1987; II (8562): 779–82

    Article  Google Scholar 

  21. Tosetti C, Stanghellini V, Paternico A, et al. Distinct functional dyspepsia subgroups characterized by different gastric emptying can be identified by an appropriate questionnaire [abstract]. Neurogastroenterol Motil 1996; 8: 195

    Google Scholar 

  22. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989; 39: 495–8

    PubMed  CAS  Google Scholar 

  23. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 (8 Suppl.): S116–28

    Google Scholar 

  24. O’Connor HJ. The role of Helicobacter pylori in peptic ulcer disease. Scand J Gastroenterol Suppl. 1994; 201: 11–5

    Article  Google Scholar 

  25. Axon ATR, Quina M. Ten-year milestones. Curr Opin Gastroenterol 1994; 10 Suppl. 1: 1–5

    Google Scholar 

  26. Lind T, van Zanten V, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with 2 antimicrobials: the MACH 1 study. Helicobacter 1996; 1 (No. 3): 138–44

    Article  PubMed  CAS  Google Scholar 

  27. Duggan A, Logan R, Knifton A, et al. Accuracy of near-patient blood tests for Helicobacter pylori [letter]. Lancet 1996; 348: 617

    Article  PubMed  CAS  Google Scholar 

  28. Wilcox MH, Dent THS, Hunter JO, et al. Accuracy of serology for the diagnosis of Helicobacter pylori infection: a comparison of eight kits. J Clin Pathol 1996; 49: 373–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Didsbury Medical Centre, 645 Wilmslow Road, Didsbury, Manchester, England

    Mark J. Whitaker

Authors
  1. Mark J. Whitaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whitaker, M.J. Consensus Guidelines for Evaluating and Treating Patients with Upper Gastrointestinal Symptoms in the Primary Care Setting. Pharmacoeconomics 14 (Suppl 2), 5–10 (1998). https://doi.org/10.2165/00019053-199814002-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199814002-00002

Keywords

Search

Navigation